These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22554999)

  • 1. A comparison of cost per case detected of screening strategies for Type 2 diabetes and impaired glucose regulation: modelling study.
    Khunti K; Gillies CL; Taub NA; Mostafa SA; Hiles SL; Abrams KR; Davies MJ
    Diabetes Res Clin Pract; 2012 Sep; 97(3):505-13. PubMed ID: 22554999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of using one- or two-HbA1c cut-point strategies to detect undiagnosed type 2 diabetes and impaired glucose regulation within a multi-ethnic population.
    Mostafa SA; Khunti K; Kilpatrick ES; Webb D; Srinivasan BT; Gray LJ; Davies MJ
    Diab Vasc Dis Res; 2013 Jan; 10(1):84-92. PubMed ID: 22773521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA Survey 2000.
    Icks A; Haastert B; Gandjour A; John J; Löwel H; Holle R; Giani G; Rathmann W;
    Diabetes Care; 2004 Sep; 27(9):2120-8. PubMed ID: 15333472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting.
    Gray LJ; Taub NA; Khunti K; Gardiner E; Hiles S; Webb DR; Srinivasan BT; Davies MJ
    Diabet Med; 2010 Aug; 27(8):887-95. PubMed ID: 20653746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should women with gestational diabetes be screened at delivery hospitalization for type 2 diabetes?
    Waters TP; Kim SY; Werner E; Dinglas C; Carter EB; Patel R; Sharma AJ; Catalano P
    Am J Obstet Gynecol; 2020 Jan; 222(1):73.e1-73.e11. PubMed ID: 31351065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of screening for diabetes and intermediate hyperglycaemia.
    Colagiuri S
    Diabetes Res Clin Pract; 2012 Sep; 97(3):341-2. PubMed ID: 22682947
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study.
    Webb DR; Gray LJ; Khunti K; Srinivasan B; Taub N; Campbell S; Barnett J; Farooqi A; Echouffo-Tcheugui JB; Griffin SJ; Wareham NJ; Davies MJ
    Diabetologia; 2011 Sep; 54(9):2237-46. PubMed ID: 21638133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
    Franciosi M; De Berardis G; Rossi MC; Sacco M; Belfiglio M; Pellegrini F; Tognoni G; Valentini M; Nicolucci A
    Diabetes Care; 2005 May; 28(5):1187-94. PubMed ID: 15855587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.
    Gillies CL; Lambert PC; Abrams KR; Sutton AJ; Cooper NJ; Hsu RT; Davies MJ; Khunti K
    BMJ; 2008 May; 336(7654):1180-5. PubMed ID: 18426840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irish diabetes detection programme in general practice.
    Smith SM; Holohan J; McAuliffe A; Firth RG
    Diabet Med; 2003 Sep; 20(9):717-22. PubMed ID: 12925050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of diagnosing Type 2 diabetes mellitus by clinical opportunistic screening in general practice.
    Pereira Gray DJ; Evans PH; Wright C; Langley P
    Diabet Med; 2012 Jul; 29(7):863-8. PubMed ID: 22313143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study.
    Sargeant LA; Simmons RK; Barling RS; Butler R; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
    Diabet Med; 2010 Sep; 27(9):995-1003. PubMed ID: 20722672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of response rates and yields for Two opportunistic Tools for Early detection of Non-diabetic hyperglycaemia and Diabetes (ATTEND). A randomised controlled trial and cost-effectiveness analysis.
    Khunti K; Gillies CL; Dallosso H; Brady EM; Gray LJ; Kilgallen G; Willis A; Zafar A; Davies MJ
    Diabetes Res Clin Pract; 2016 Aug; 118():12-20. PubMed ID: 27485852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance.
    Liu M; Pan C; Jin M
    Diabetes Technol Ther; 2011 May; 13(5):501-7. PubMed ID: 21406016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and effectiveness of screening methods for abnormal fasting plasma glucose among Thai adults participating in the annual health check-up at King Chulalongkorn Memorial Hospital.
    Srichang N; Jiamjarasrangsi W; Aekplakorn W; Supakankunti S
    J Med Assoc Thai; 2011 Jul; 94(7):833-41. PubMed ID: 21774291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of alternative indicators for screening for diabetes mellitus.
    Shirasaya K; Miyakawa M; Yoshida K; Takahashi E; Shimada N; Kondo T
    Prev Med; 1999 Aug; 29(2):79-86. PubMed ID: 10446032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
    Icks A; Rathmann W; Haastert B; John J; Löwel H; Holle R; Giani G;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S167-71. PubMed ID: 16032536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance.
    Wong CK; Jiao FF; Siu SC; Fung CS; Fong DY; Wong KW; Yu EY; Lo YY; Lam CL
    J Diabetes Res; 2016; 2016():1219581. PubMed ID: 26798647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian Diabetes Screening Study: impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Welborn TA; Reid CM; Marriott G
    Metabolism; 1997 Dec; 46(12 Suppl 1):35-9. PubMed ID: 9439557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.